MarketInOut Stock Screener Log In | Sign Up
 

First Tracks Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
First Tracks Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,473.9 mln
Float30.36 mln
Earnings Date11/05/2026

1-Year Forecast

74.17
Transformational upside

Relative Strength

99 / 100
Top performer

Debt / Equity

0.03
Debt-free

ROE

-39.35
Deeply negative

ROA

-35.40
Deeply negative

Business Description

First Tracks Biotherapeutics is a clinical-stage company based in San Diego, California, working to develop treatments for autoimmune and inflammatory diseases. The company has three drug candidates in its pipeline, each designed to reduce harmful immune activity through distinct biological pathways. Founded in 2019 and formerly known as Biopharma Co. Inc., the company changed its name in February 2026.

Key Fundamentals

EPS-4.71
ROE-39.35
ROIC-1,109
ROA-35.40
EBITDA, mln-83.53
EV / EBITDA-13.40
EV / EBIT-13.35

Quote Details

Last 44.05
Change 0.91 (2.11%)
Open 43.13
Volume 849,495
Turnover 37,420,256
Average Volume 1,181,038

Financial Ratios

Leverage Ratio1.08
Current Ratio14.28
Price / Book7.53
Price / Tangible Book7.53
Debt / Equity0.03

Financial Strength

1-Year Target Price74.17
Short Ratio7.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 27.83% 99 / 100   
1 Month 22.94% 97 / 100   
2 Months 19.47% 92 / 100   
6 Months 143% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog